Calithera Biosciences Sharply Higher After FDA Fast Track Designation

Loading...
Loading...

Calithera Biosciences Inc CALA shares are trading higher by $1.45 (10 percent) at $16.85 in Wednesday's session.

Before the open, the company reported it received FDA Fast Track Designation for CB-839 for the treatment of patients with Renal Cell Carcinoma.

After a higher open, Calithera had a brief retreat but found support above Tuesday's close ($15.40) at $15.65 and continued its move higher. It took the stock to $17.25, but has fallen back to the $17.00 area.

That high comes in just above its May 24 high ($17.20), but is shy of its May 23 high ($17.40).

Posted In: TechnicalsIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...